Clinical Trial Update: Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer [Phase 1]

View source ↗

Summary

A Phase I, genotype-guided trial evaluates irinotecan given with neoadjuvant chemoradiotherapy for patients with stage II/III rectal cancer. The study aims to a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Fudan University | Conditions: Rectal Cancer | Phase 1 | Status: UNKNOWN